1887
Volume 2014, Issue 3
  • ISSN: 2305-7823
  •  E-ISSN:  Will be obtained soon

Abstract

The role of cardiac resynchronization therapy (CRT) in patients presenting with mild manifestations of heart failure (HF), depressed left ventricular ejection fraction (LV EF), and wide QRS complex, has been addressed in four previous trials: MIRACLE ICD II,1 MADIT-CRT,2 RAFT,3 and REVERSE.4 The consistent observed benefits in reverse cardiac remodelling and reduction of heart failure adverse events have resulted in guideline recommendations for CRT in NYHA Class II patients. The guidelines also recommend further studies to determine whether survival is increased by CRT in patients with mild symptoms. The 5-year analysis of the REsynchronization reVErses Remodeling Systolic left vEntricular (REVERSE) trial, which was designed prospectively for 5-year follow-up to specifically assess the long term benefits of CRT, were recently published in the .5

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2014.39
2014-12-01
2020-05-30
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/3/gcsp.2014.39.html?itemId=/content/journals/10.5339/gcsp.2014.39&mimeType=html&fmt=ahah

References

  1. Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group . Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation. 2004; 110:18:28642868, Available at: http://www.ncbi.nlm.nih.gov/pubmed/15505095. Accessed September 9, 2014.
    [Google Scholar]
  2. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators . Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009; 361:14:13291338, Available at: http://www.ncbi.nlm.nih.gov/pubmed/19723701. Accessed August 30, 2014.
    [Google Scholar]
  3. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators . Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010; 363:25:23852395, Available at: http://www.ncbi.nlm.nih.gov/pubmed/21073365. Accessed August 27, 2014.
    [Google Scholar]
  4. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008; 52:23:18341843, Available at: http://www.ncbi.nlm.nih.gov/pubmed/19038680. Accessed August 27, 2014.
    [Google Scholar]
  5. Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group . Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J. 2013; 34:33:25922599, Available at: http://www.ncbi.nlm.nih.gov/pubmed/23641006. Accessed September 9, 2014.
    [Google Scholar]
  6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352:15:15391549, Available at: http://www.ncbi.nlm.nih.gov/pubmed/15753115. Accessed August 8, 2014.
    [Google Scholar]
  7. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators . Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350:21:21402150, Available at: http://www.ncbi.nlm.nih.gov/pubmed/15152059. Accessed August 8, 2014.
    [Google Scholar]
  8. Ploux S, Lumens J, Whinnett Z, Montaudon M, Strom M, Ramanathan C, Derval N, Zemmoura A, Denis A, De Guillebon M, Shah A, Hocini M, Jaïs P, Ritter P, Haïssaguerre M, Wilkoff BL, Bordachar P. Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology. J Am Coll Cardiol. 2013; 61:24:24352443, Available at: http://www.ncbi.nlm.nih.gov/pubmed/23602768. Accessed September 1, 2014.
    [Google Scholar]
  9. Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert J-C. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Eur Heart J. 2011; 32:13:16311639, Available at: http://www.ncbi.nlm.nih.gov/pubmed/21112898. Accessed September 9, 2014.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2014.39
Loading
/content/journals/10.5339/gcsp.2014.39
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error